Legend Shares Owned by Institutions

LEGN Stock

USD 46.06 2.24 5.11%

Legend BiotechCorp fundamentals help investors to digest information that contributes to Legend BiotechCorp's financial success or failures. It also enables traders to predict the movement of Legend Stock. The fundamental analysis module provides a way to measure Legend BiotechCorp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Legend BiotechCorp stock.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Current Assets Total Assets

Legend Shares Owned by Institutions Analysis

Legend BiotechCorp's Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.

	2020	2021	2022	2023 (projected)
Interest Expense	4.21 M	900 K	1.03 M	1.33 M
Gross Profit	75 M	68.83 M	79.15 M	78.27 M

Interest Expense Gross Profit

Shares Held by Institutions

Funds and Banks

Firms

More About Shares Owned by Institutions | All Equity Analysis

Current Legend BiotechCorp Shares Owned by Institutions

38.67 %

Most of Legend BiotechCorp's fundamental indicators, such as Shares Owned by Institutions, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Legend BiotechCorp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Legend Shares Owned by Institutions Driver Correlations

Understanding the fundamental principles of building solid financial models for Legend BiotechCorp is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Shares Owned by Institutions. Since Legend BiotechCorp's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Legend BiotechCorp's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Legend BiotechCorp's interrelated accounts and indicators.

	Total Assets	Current Assets	Cash and Equivalents	Total Debt	Debt Current	Deferred Revenue	Shareholders Equity	Investments Current	Total Liabilities	Current Liabilities	Tax Assets	Tax Liabilities
Total Assets		1.0	0.97	0.94	0.64	0.86	0.98	0.91	0.97	0.97	-0.76	-0.76
Current Assets	1.0		0.97	0.94	0.64	0.86	0.98	0.91	0.97	0.97	-0.75	-0.75
Cash and Equivalents	0.97	0.97		0.97	0.69	0.92	0.99	0.93	0.97	0.95	-0.82	-0.82
Total Debt	0.94	0.94	0.97		0.55	0.89	0.93	0.99	0.98	0.97	-0.84	-0.84
Debt Current	0.64	0.64	0.69	0.55		0.78	0.67	0.41	0.56	0.48	-0.48	-0.48
Deferred Revenue	0.86	0.86	0.92	0.89	0.78		0.88	0.83	0.89	0.83	-0.91	-0.91
Shareholders Equity	0.98	0.98	0.99	0.93	0.67	0.88		0.91	0.94	0.94	-0.78	-0.78
Investments Current	0.91	0.91	0.93	0.99	0.41	0.83	0.91		0.97	0.97	-0.83	-0.83
Total Liabilities	0.97	0.97	0.97	0.98	0.56	0.89	0.94	0.97		0.99	-0.84	-0.84
Current Liabilities	0.97	0.97	0.95	0.97	0.48	0.83	0.94	0.97	0.99		-0.8	-0.8
Tax Assets	-0.76	-0.75	-0.82	-0.84	-0.48	-0.91	-0.78	-0.83	-0.84	-0.8		1.0
Tax Liabilities	-0.76	-0.75	-0.82	-0.84	-0.48	-0.91	-0.78	-0.83	-0.84	-0.8	1.0

Click cells to compare fundamentals

Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.

Competition

Predict Legend BiotechCorp

Based on the latest financial disclosure, 38.67% of Legend BiotechCorp are shares owned by institutions. This is 13.37% lower than that of the Healthcare sector and 18.59% lower than that of the Biotechnology industry. The shares owned by institutions for all United States stocks is 1.38% higher than that of the company.

Legend Shares Owned by Institutions Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Legend BiotechCorp's direct or indirect competition against its Shares Owned by Institutions to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Legend BiotechCorp could also be used in its relative valuation, which is a method of valuing Legend BiotechCorp by comparing valuation metrics of similar companies.

Legend BiotechCorp is currently under evaluation in shares owned by institutions category among related companies.

Legend BiotechCorp Institutional Holders

Institutional Holdings refers to the ownership stake in Legend BiotechCorp that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Legend BiotechCorp's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Legend BiotechCorp's value.

	Last Transaction	Type	Shares	Value
Fmr Llc	2022-12-31	Common Shares	15.1 M	755.9 M
Hhlr Advisors Ltd	2022-12-31	Common Shares	5.1 M	256.4 M
Blackrock Inc	2022-12-31	Common Shares	3.9 M	193.6 M
Ra Capital Management Lp	2022-12-31	Common Shares	2.4 M	121.6 M
Capital World Investors	2022-12-31	Common Shares	2.4 M	119.3 M
Federated Hermes Inc	2022-12-31	Common Shares	2.3 M	116.8 M
Capital International Investors	2022-12-31	Common Shares	2.2 M	108.3 M
Janus Henderson Group Plc	2022-12-31	Common Shares	1.8 M	92.2 M
Wellington Management Group Llp	2022-12-31	Common Shares	1.8 M	90.5 M
Johnson Johnson	2022-12-31	Common Shares	1.6 M	81.3 M
Alliancebernstein Lp	2022-12-31	Common Shares	1.3 M	64.5 M

Legend Fundamentals

	Return On Equity	(0.97) %
	Return On Asset	(0.26) %
	Operating Margin	(3.29) %
	Current Valuation	8.02 B
	Shares Outstanding	167.4 M
	Shares Owned by Insiders	1.36 %
	Shares Owned by Institutions	38.67 %
	Number of Shares Shorted	5.11 M
	Price to Book	19.80 X
	Price to Sales	73.18 X
	Revenue	89.79 M
	Gross Profit	91.56 M
	EBITDA	(385.31 M)
	Net Income	(386.21 M)
	Cash and Equivalents	791.26 M
	Cash per Share	5.11 X
	Total Debt	120.46 M
	Debt to Equity	0.29 %
	Current Ratio	3.83 X
	Book Value Per Share	3.63 X
	Cash Flow from Operations	(198.47 M)
	Short Ratio	6.70 X
	Earnings Per Share	(2.81) X
	Target Price	71.29
	Number of Employees	1.07 K
	Beta	-0.0875
	Market Capitalization	7.71 B
	Total Asset	1.12 B
	Z Score	38.4
	Net Asset	1.12 B

About Legend BiotechCorp Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Legend BiotechCorp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Legend BiotechCorp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Legend BiotechCorp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Legend Biotech Corporation is a subsidiary of Genscript Biotech Corporation. Legend Biotech operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 1071 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Legend BiotechCorp without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Correlation Analysis Now

Correlation Analysis

Reduce portfolio risk simply by holding instruments which are not perfectly correlated

All Next

Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Legend BiotechCorp using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Fix portfolios for free

Check out Legend BiotechCorp Piotroski F Score and Legend BiotechCorp Altman Z Score analysis. To learn how to invest in Legend Stock please use our How to Invest in Legend BiotechCorp guide. Note that the Legend BiotechCorp information on this page should be used as a complementary analysis to other Legend BiotechCorp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try CEO Directory module to screen CEOs from public companies around the world.

Complementary Tools for Legend Stock analysis

When running Legend BiotechCorp price analysis, check to measure Legend BiotechCorp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Legend BiotechCorp is operating at the current time. Most of Legend BiotechCorp's value examination focuses on studying past and present price action to predict the probability of Legend BiotechCorp's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Legend BiotechCorp's price. Additionally, you may evaluate how the addition of Legend BiotechCorp to your portfolios can decrease your overall portfolio volatility.

	Equity Valuation Check real value of public entities based on technical and fundamental data
	CEO Directory Screen CEOs from public companies around the world
	Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
	Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format

Is Legend BiotechCorp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend BiotechCorp. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend BiotechCorp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.81)

Revenue Per Share

0.788

Quarterly Revenue Growth

(0.42)

Return On Assets

(0.26)

Return On Equity

(0.97)

The market value of Legend BiotechCorp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend BiotechCorp's value that differs from its market value or its book value, called intrinsic value, which is Legend BiotechCorp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend BiotechCorp's market value can be influenced by many factors that don't directly affect Legend BiotechCorp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Legend BiotechCorp's value and its price as these two are different measures arrived at by different means. Investors typically determine Legend BiotechCorp value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend BiotechCorp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2023 Macroaxis LLC

Legend Shares Owned by Institutions

Legend Shares Owned by Institutions Analysis

Current Legend BiotechCorp Shares Owned by Institutions

Legend Shares Owned by Institutions Driver Correlations

Legend Shares Owned by Institutions Peer Comparison

Legend BiotechCorp Institutional Holders

Legend Fundamentals

About Legend BiotechCorp Fundamental Analysis

Be your own money manager

Did you try this?

Run Correlation Analysis Now

Correlation Analysis

Becoming a Better Investor with Macroaxis

Build Optimal Portfolios

Align your risk with return expectations

Complementary Tools for Legend Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY